股本结构
单位：万股
| 公告日期 | 2026-08-13 | 2026-08-13 | 2026-05-13 | 2026-05-13 | 2026-03-16 | 2026-03-16 |
|---|---|---|---|---|---|---|
| 证券总股本 | 6517.67 | 6333.07 | 6313.34 | 6238.34 | 5737.10 | 5736.13 |
| 普通股本 | 6517.67 | 6333.07 | 6313.34 | 6238.34 | 5737.10 | 5736.13 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-07-31 | 2026-06-30 | 2026-04-30 | 2026-03-31 | 2026-03-12 | 2026-02-28 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-08-13 | 6517.67 | 未披露 | 定期报告 | 2026-07-31 |
| 2026-08-13 | 6333.07 | 未披露 |
更多>>
From March 31,2026 to June 30,2026
Exercises of common stock options
Vesting of restricted stock units
Issuance of common stock from underwriters' exercise of the overallotment option of equity offering in full, net of underwriting commissions and other offering costs
|
2026-06-30 |
| 2026-05-13 | 6313.34 | 未披露 | 定期报告 | 2026-04-30 |
| 2026-05-13 | 6238.34 | 未披露 |
更多>>
From December 31, 2025 to March 31, 2026
Exercises of common stock options
Purchases of common stock under the Employee Stock Purchase Plan
Issuance of common stock from ATM offering, net of underwriting commissions and other offering costs
Issuance of common stock from equity offering, net of underwriting commissions and other offering costs
|
2026-03-31 |
| 2026-03-16 | 5737.10 | 未披露 | 定期报告 | 2026-03-12 |
| 2026-03-16 | 5736.13 | 未披露 | 定期报告 | 2026-02-28 |
| 2026-03-16 | 5448.55 | 未披露 |
更多>>
From December 31, 2024 to December 31, 2025
Exercises of common stock options
Purchases of common stock under the Employee Stock Purchase Plan
Issuance of common stock from PIPE offering, net of placement agent fees and other offering costs
Equity consideration related to InnoCare License Agreement
Issuance of common stock from ATM offering, net of commissions and other offering costs
|
2025-12-31 |
| 2025-11-12 | 5367.92 | 未披露 | 定期报告 | 2025-10-31 |
| 2025-10-21 | 5352.45 | 未披露 | 定期报告 | 2025-10-09 |
| 2025-11-12 | 4221.35 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Exercises of common stock options
Purchases of common stock under the Employee Stock Purchase Plan
|
2025-09-30 |
| 2025-08-12 | 4211.03 | 未披露 | 定期报告 | 2025-07-31 |
| 2025-08-12 | 4208.87 | 未披露 |
更多>>
From March 31, 2025 to June 30, 2025
Exercises of common stock options
|
2025-06-30 |
| 2025-04-28 | 4183.42 | 未披露 | 定期报告 | 2025-04-14 |
| 2025-05-15 | 4182.19 | 未披露 |
更多>>
From December 31, 2024 to March 31, 2025
Exercises of common stock options
|
2025-03-31 |
| 2025-03-11 | 4179.93 | 未披露 | 定期报告 | 2025-02-28 |
| 2025-03-11 | 4179.34 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Repurchase of unvested restricted stock awards
Conversion of convertible preferred stock to common stock upon closing of initial public offering
Issuance of common stock from initial public offering, net of underwriting discounts, commissions and other issuance costs
Exercises of common stock options
|
2024-12-31 |
| 2024-11-12 | 4179.10 | 未披露 | 定期报告 | 2024-10-31 |
| 2024-11-12 | 4178.09 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Conversion of convertible preferred stock to common stock upon closing of initial public offering
Issuance of common stock from initial public offering, net of $6,250 of issuance costs
Exercises of common stock options
|
2024-09-30 |
| 2024-11-12 | 4177.77 | 未披露 |
更多>>
On September 16, 2024, the Company completed its initial public offering (“IPO”), in which the Company issued and sold 15,220,588 shares of its common stock, including 1,985,294 shares pursuant to the full exercise of the underwriters’ option to purchase additional shares, at a public offering price of $17.00 per share, for aggregate gross proceeds of $258.7 million.
|
2024-09-16 |
| 2024-09-13 | 3979.24 | 未披露 |
更多>>
Common stock offered 13,235,294 shares by the company
|
2024-09-13 |
From March 31,2026 to June 30,2026
Exercises of common stock options
Vesting of restricted stock units
Issuance of common stock from underwriters' exercise of the overallotment option of equity offering in full, net of underwriting commissions and other offering costs
From December 31, 2025 to March 31, 2026
Exercises of common stock options
Purchases of common stock under the Employee Stock Purchase Plan
Issuance of common stock from ATM offering, net of underwriting commissions and other offering costs
Issuance of common stock from equity offering, net of underwriting commissions and other offering costs
From December 31, 2024 to December 31, 2025
Exercises of common stock options
Purchases of common stock under the Employee Stock Purchase Plan
Issuance of common stock from PIPE offering, net of placement agent fees and other offering costs
Equity consideration related to InnoCare License Agreement
Issuance of common stock from ATM offering, net of commissions and other offering costs
From June 30, 2025 to September 30, 2025
Exercises of common stock options
Purchases of common stock under the Employee Stock Purchase Plan
From March 31, 2025 to June 30, 2025
Exercises of common stock options
From December 31, 2024 to March 31, 2025
Exercises of common stock options
From December 31, 2023 to December 31, 2024
Repurchase of unvested restricted stock awards
Conversion of convertible preferred stock to common stock upon closing of initial public offering
Issuance of common stock from initial public offering, net of underwriting discounts, commissions and other issuance costs
Exercises of common stock options
From June 30, 2024 to September 30, 2024
Conversion of convertible preferred stock to common stock upon closing of initial public offering
Issuance of common stock from initial public offering, net of $6,250 of issuance costs
Exercises of common stock options
On September 16, 2024, the Company completed its initial public offering (“IPO”), in which the Company issued and sold 15,220,588 shares of its common stock, including 1,985,294 shares pursuant to the full exercise of the underwriters’ option to purchase additional shares, at a public offering price of $17.00 per share, for aggregate gross proceeds of $258.7 million.
Common stock offered 13,235,294 shares by the company